Hemab Therapeutics
PrivateLast Round
Series C
Oct 27, 2025
Total Funding Raised
$157M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
-
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemab Therapeutics Comparables
Compare Hemab Therapeutics with similar companies based on industry and business-model similarity.
Hemab Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 27, 2025 |
Hemab Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maj Invest Equity A/S | Series C |
| RA Capital Management | Series C |
| Avoro Ventures | Series C |
| Avoro Capital | Series C |
| Deep Track Capital | Series C |
| HealthCap | Series C |
| Novo Holdings | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
$157M round raised.
Hemab Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemab Therapeutics's valuation, stock price, and market status.